BillionToOne, Inc. (BLLN) stock
BLLNNasdaqServices-Medical LaboratoriesFiscal year ends December 31
$89.92−0.28 (-0.31%)
Close on Nov 20, 2026Market cap $4.24BP/E –Yield –
BillionToOne gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
BillionToOne's gross profit for the twelve months ending Sep 30, 2026 was $311.95M, up 88.4% year over year. For fiscal 2025 it was $208.46M, up 157.6% from the year before.
Annual gross profit
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $208.46M | +157.6% |
| FY2024 | Dec 31, 2024 | $80.92M | +367.5% |
| FY2023 | Dec 31, 2023 | $17.31M | – |
Quarterly gross profit
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $87.15M | +49.2% |
| Q2 FY2026 | Jun 30, 2026 | $77.11M | +77.4% |
| Q1 FY2026 | Mar 31, 2026 | $79.10M | +108.3% |
| Q4 FY2025 | Dec 31, 2025 | $68.60M | +166.7% |
| Q3 FY2025 | Sep 30, 2025 | $58.42M | +189.0% |
| Q2 FY2025 | Jun 30, 2025 | $43.47M | – |
| Q1 FY2025 | Mar 31, 2025 | $37.97M | – |
| Q4 FY2024 | Dec 31, 2024 | $25.72M | – |
| Q3 FY2024 | Sep 30, 2024 | $20.22M | – |
See a number that looks wrong?